NIH-Funded Researchers Develop Promising Candidate for Next-Generation Anti-Malarial Drug
Friday, March 11, 2016 - 04:40
in Health & Medicine
An international team that includes NIH-funded researchers at Stanford University has developed a therapeutic compound that is effective in inhibiting Plasmodium falciparum, one of five species of parasite that infects people with malaria, and the strain which causes the highest number of malaria deaths.
